跳至主要内容
临床试验/CTRI/2020/10/028229
CTRI/2020/10/028229尚未招募2 期

Single arm clinical study to evaluate efficacy of Udumbar Twak Ghanvati in Asrugdara.

Dr Sayali Gourishankar Belage1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年10月21日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
1)Asrugdara is the common problem noticed in majority of patients in our clinical practice.

研究概览

简要总结

Aim of the study will be to give ayurvedic treatment to diseased patient to improve her condition and we can give her cheap, safe side effect free management .

The trial will be conducted on 60 patients for 3 consecutive cycle of 1st 5 days of menstrual flow and dose will be 500mg once in a day and conclusion will be drawn from the collected data.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
15.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Written informed consent & voluntarily willing patients will be taken for this study. 2)Patients complaining of excessive or prolonged menstrual bleeding or inter menstrual bleeding for 2 consecutive cycles. 3)Hb %.
  • Above 8 gm%.

排除标准

  • Patients with IUCD and on OC pills or on hormonal treatment.
  • PCOD,STD,Blood coagulopathy.
  • Immuno– compromised patients.
  • Associated with other systemic diseases like HTN, TB, DM.
  • Bleeding from polyps,fibroid, Ca, erosions, trauma etc.
  • On medication like Aspirin, clopitab.

结局指标

主要结局

1)Asrugdara is the common problem noticed in majority of patients in our clinical practice.

时间窗: Patient should be assessed for 3 consecutive cycles for 1st 5 days of menstrual flow

2) To evatuate and establish safer,cost-effective Ayurvedic remedy for Asrugdara.

时间窗: Patient should be assessed for 3 consecutive cycles for 1st 5 days of menstrual flow

次要结局

  • 1)To improve physiological condition(2)To give her a safe cheap side effect free ayurvedic management)

研究者

发起方
Dr Sayali Gourishankar Belage
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验